“Progesterone Receptor Antagonists – A Novel Treatment for Severe Hyponatremia from the Endocrine Paraneoplastic Syndrome”, JGPRT, vol. 1, no. 1, Apr. 2026, doi: 10.67164/c4dwkh15.